Search
Loading...
1,137 Results
'A wonderful experience I will never forget': AKF Ambassador Shante Byrd's inside look at AKF's 2023 Kidney Action Summit
AKF Ambassador Shante Byrd shares her experience of traveling to D.C. to meet with her elected officials during this year's Kidney Action Summit, sharing h...
Vadadustat for CKD-related anemia may gain FDA approval
The FDA will no longer require Akebia Therapeutics to submit new data for vadadustat as a treatment for chronic kidney disease (CKD)-associated anemia in dialys...
Lexicon's heart failure drug Inpefa gets FDA nod
Lexicon Pharmaceuticals' Inpefa, or sotagliflozin, has obtained FDA approval for lowering the risk of heart failure-related hospitalizations, cardiovascula...
FDA fast tracks drug candidate for lupus nephritis
Kyverna Therapeutics' fully human anti-CD19 chimeric antigen receptor T-cell therapy, KYV-101, was granted fast-track designation by the FDA as a treatment...
Analysis: Routine screening for CKD beneficial
An analysis published in the journal Annals of Internal Medicine found that routine screening for chronic kidney disease (CKD) in all adults is cost-effective a...
Racial disparities persist in home dialysis utilization
A study published in the American Journal of Managed Care found racial disparities in home dialysis remained among patients with end-stage renal disease (ESRD) ...
Abnormalities detected on kidney ultrasound after first febrile UTI
A study published in JAMA Pediatrics found that urinary tract abnormalities were detected on kidney ultrasonography in 21.9% of children younger than 24 months ...
Benzbromarone for hyperuricemia tied to lower CKD risk
Research published in the European Journal of Internal Medicine found patients with asymptomatic hyperuricemia who used urate-lowering drug benzbromarone had a ...
CDC: Almost all Americans have SARS-CoV-2 antibodies
A study published in the CDC's Morbidity and Mortality Weekly Report estimates that 96% of Americans ages 16 and older had antibodies against SARS-CoV-2 fr...
